Compare · AMED vs EHAB
AMED vs EHAB
Side-by-side comparison of Amedisys Inc (AMED) and Enhabit Inc. (EHAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMED and EHAB operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- AMED is the larger of the two at $4.20B, about 5.9x EHAB ($706.9M).
- EHAB has hit the wire 1 time in the past 4 weeks while AMED has been quiet.
- AMED has more recent analyst coverage (25 ratings vs 19 for EHAB).
- Company
- Amedisys Inc
- Enhabit Inc.
- Price
- $100.98-0.00%
- $13.80+0.00%
- Market cap
- $4.20B
- $706.9M
- 1M return
- +3.66%
- -
- 1Y return
- +7.08%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 1
- Recent ratings
- 25
- 19
Amedisys Inc
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Enhabit Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Latest AMED
- SEC Form 15-12G filed by Amedisys Inc
- Twilio Set to Join S&P MidCap 400
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
Latest EHAB
- SEC Form 15-12G filed by Enhabit Inc.
- SEC Form S-8 POS filed by Enhabit Inc.
- SEC Form S-8 POS filed by Enhabit Inc.
- President and CEO Jacobsmeyer Barbara Ann returned $16,704,541 worth of shares to the company (1,210,474 units at $13.80) and was granted 603,767 shares, closing all direct ownership in the company (SEC Form 4)
- General Counsel and Secretary Black Dylan C returned $2,869,144 worth of shares to the company (207,909 units at $13.80) and was granted 108,086 shares, closing all direct ownership in the company (SEC Form 4)
- EVP of Home Health Operations Jolley Julie Diane returned $3,678,238 worth of shares to the company (266,539 units at $13.80) and was granted 129,409 shares, closing all direct ownership in the company (SEC Form 4)
- Chief Human Resources Officer Marion Tanya Renee returned $2,904,031 worth of shares to the company (210,437 units at $13.80) and was granted 103,674 shares, closing all direct ownership in the company (SEC Form 4)
- EVP of Hospice Operations Kalvaitis Jeanne Louise returned $1,593,900 worth of shares to the company (115,500 units at $13.80) and was granted 53,625 shares, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Enhabit Inc.
- Director Rodgers Stephan returned $294,464 worth of shares to the company (21,338 units at $13.80), closing all direct ownership in the company (SEC Form 4)